DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA341503
Title:
Regulation and Mechanism of Action of the c-Myc Proto-Oncogene in Human Breast Cancer.
Descriptive Note:
Annual rept. 1 Oct 96-30 Sep 97.
Corporate Author:
COLUMBIA UNIV NEW YORK
Report Date:
1997-10-01
Pagination or Media Count:
30.0
Abstract:
Our studies on transcriptional regulation of the c-myc proto-oncogen are divided into two subprojects i studies on Blimp-1, a transcriptional repressor of c-myc and ii studies to determine the mechanism by which estrogen induces c-myc transcription in estrogen-dependent breast cancer cells. Blimp-1 was initially identified as a master-regulator of B-lymphocyte differentiation and was thought to be B-cell specific. We recently showed that Blimp-1 is a site specific repressor of c-myc ye transcription. Our studies reported here provide evidence that Blimp-1 plays a role in terminal differentiation of many cell lineages. We show that Blimp-1 mRNA is induced upon terminal differentiation of promyelocytic cells in culture and that Blimp-1 mRNA is present in many adult tissues. We have also demonstrated the ability of Blimp-1 to repress growth of MCF-7 breast cancer cells, which depend upon c-Myc activity for their transformed growth. In the second project, runon transcription has been used to show that estrogen induces transcription initiation but does not alter polymerase processivity on the c-myc gene in MCF-7 cells. We have identified four DNaseI hypersensitivity sites in the c-myc gene which are induced in response to estrogen. They are good candidates to be unusual estrogen response elements.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE